Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Engineered virus-like particles for in vivo gene editing ameliorate hearing loss in murine DFNA2 model

2 Sept 2025

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRISPR and Genetic Engineering
Share to RNA regulation and disease
Share to Viral Infections and Immunology Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 40898619
DOI: 10.1016/j.ymthe.2025.08.049

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Engineered virus-like particles for in vivo gene editing ameliorate hearing loss in murine DFNA2 modelPMID 40898619Read ↗

Precise and efficient DNA base editing restores normal hearing in adult DFNB9 mouse model.Semantic proximity Read ↗

PAM-flexible adenine base editing rescues hearing loss in a humanized <i>MPZL2</i> mouse model harboring an East Asian founder mutationSemantic proximity Read ↗

PAM-flexible adenine base editing rescues hearing loss in a humanized MPZL2 mouse model harboring an East Asian founder mutationSemantic proximity Read ↗

The development of inner ear gene therapy for DFNB9: From bench to bedside.Semantic proximity Read ↗

Gene therapy for hearing loss.Semantic proximity Read ↗

<i>In vivo</i> -directed evolution identifies AAV-WM04 as a next-generation vector for potent and durable hearing restoration in DFNB9Semantic proximity Read ↗

Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivoSemantic proximity Read ↗

Template-independent genome editing and repairing correct frameshift disease <i>in vivo</i>Semantic proximity Read ↗

Gene Therapy for Inherited Hearing Loss: Updates and Chal-lengesSemantic proximity Read ↗

Viral and non-viral vectors in gene therapy: current state and clinical perspectivesSemantic proximity Read ↗

Combination of engineered cell type-specific promoters and a high-efficiency AAV capsid restores hearing in adult DFNB1 mice model with demonstrated safety in nonhuman primateSemantic proximity Read ↗

Advances in genome editing for genetic hearing loss.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.